Drug Management in End-of-Life Hospitalized Palliative Care Cancer Patients: The RHESO Cohort Study

Conclusions: NACT prescription remained commonplace in terminally ill palliative cancer patients, although their benefit is questionable.Oncology
Source: Oncology - Category: Cancer & Oncology Source Type: research